Mollie Leoni
Fortune : 2 M $ au 30/06/2026
Fortune : 2 M $ au 30/06/2026
Mollie Leoni is currently Chief Medical Officer at Kura Oncology, Inc. since 2025.
Formerly, worked as Executive Director-Medical Science at Kyowa Kirin Ltd. from 2018 to 2020 and at Kyowa Kirin Co., Ltd. Education includes undergraduate and doctorate degrees from the University of Pennsylvania.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
KURA ONCOLOGY, INC. 0,21 % | 18/06/2026 | 182 345 ( 0,21 % ) | 2 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| KURA ONCOLOGY, INC. | Directeur Technique/Scientifique/R&D | 02/01/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
Kyowa Kirin Ltd.
Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products | Directeur Technique/Scientifique/R&D | 01/02/2020 |
| KYOWA KIRIN CO., LTD. | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Kura Oncology, Inc.
Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals; develops biochemical reagents and other chemicals | Health Technology |
Kyowa Kirin Ltd.
Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national